The Feinstein Institute for Medical Research

Manhasset, New York 11031

2 studies enrolling now · 30 studies all time

What they study most

Acute Coronary Syndrome, Agitation, Alzheimer Disease, Brain Function, Chronic Disease, Coronary Artery Disease, Diamond Blackfan Anemia, Healthy, Healthy Participants, Human Blood Cell Disorders, Immune System Diseases, Lupus

Studies at this site

• Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease — Recruiting now
• Human Blood Cell Disorders Tissue Bank — Recruiting now
• Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) — Completed
• Development of Novel Measures for Alzheimer's Disease Prevention Trials — Paused
• A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease — Completed
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• A Study of Guselkumab in Participants With Active Lupus Nephritis — Stopped early
• Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus — Completed
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early
• The Use of Trifluoperazine in Transfusion Dependent DBA — Stopped early
• Tailored Antiplatelet Therapy Following PCI — Completed
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• Gastrointestinal and Urinary Tract Microbiome After SCI — Completed
• Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation — Stopped early
• Nelfinavir in Systemic Lupus Erythematosus — Stopped early
• Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus — Completed
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) — Stopped early
• A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus — Stopped early
• Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus — Completed
• Autoimmunity in Sisters of Lupus Patients — Completed
• BioGene Bank Cohort Study for Approved Research Requests — Completed
• Genotype and Phenotype Registry: Enrollment of Normal Control Subjects for Current and Future Research — Completed
• The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis — Stopped early
• Parkinson's Disease Genetics Database — Stopped early
• Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways — Completed
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• Correlation of Laparoscopic Experience and Functional Brain Activation: A PET Scan Study — Completed
• Vagus Nerve Stimulation in Rheumatoid Arthritis — Stopped early